Bone Marrow Transplantation and Immune Deficiency

Fig A: These magnetic resonance images show responses in two patients with recurrent sonic hedgehog–subgroup medullo-blastoma (MB) treated with vismodegib. Images were obtained at the start of therapy and at 2, 4, and 6 months after. Gold arrows indicate recurrent lesions. After initial response, MB recurs locally.

Featured Research

Vismodegib Shows Promise in Recurrent Medulloblastoma Sonic Hedgehog Subgroup

A drug that has helped some people with basal cell carcinoma also shows promise as an improved therapy for a subgroup of people with recurrent medulloblastomas.

Read More

Research and Training Details

Faculty15
Joint Appointment Faculty4
Research Fellows and Post Docs1
Research Graduate Students1
Total Annual Grant Award Dollars$1,284,076
Total Annual Industry Award Dollars$257,680
Total Publications51

Clinical Activities and Training

Staff Physicians9
Clinical Fellows5
Inpatient Encounters11,502
Outpatient Encounters7,482